IART FY 2024 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.6B+4.5% YoY

Gross Profit

$882M54.8% margin

Operating Income

$28M1.8% margin

Net Income

-$7M-0.4% margin

EPS (Diluted)

$-0.09

Cash Flow

Operating Cash Flow

$129M

Free Cash Flow

$25M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$4.0B

Total Liabilities

$2.5B

Stockholders' Equity

$1.5B

Cash & Equivalents

$246M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$1.5B	+4.5%
Gross Profit	$882M	$885M	-0.3%
Operating Income	$28M	$112M	-74.5%
Net Income	-$7M	$68M	-110.3%